| 2026 Hunter's Hope Symposium | ||||
| Monday, July 13th | DRAFT AGENDA | |||
| All Day | ALL TIMES in Eastern Time Zone | Arrive/Check In | Tamarack Lobby | |
| Tuesday, July 14th | 8AM - 5PM ET | |||
| Start Time | Stop Time | Topic/Event | Speaker | Location |
| 7:00 AM | 7:50 AM | Breakfast | Fairway, 2nd Floor, HV Lodge | |
| 8:00 AM | 8:10 AM | Welcome and Introduction | Dr. Robert Thompson Stone and Anna Grantham | |
| Session One: Leukodystrophy Newborn Screening Updates and Discussion | ||||
| Updates in NBS for ALD, KD, MLD and CTX in U.S.State Labs | Dr. Joseph Orsini | |||
| The Evolving Story of Mildly Elevated Psychosine in NBS | Dr. Dieter Matern | |||
| Panel Discussion: Newborn Screening for Krabbe Disease | ||||
| BREAK | ||||
| Follow-up Protocol for Positive MLD NBS | Dr. Laura Adang | |||
| Panel Discussion: Cases in KD, MLD, and ALD NBS | Dr. Laura Adang | |||
| Family Perspective | ||||
| 12:00 PM | 1:00 PM | LUNCH | Sunrise, 1st Floor HV Lodge | |
| Krabbe Disease: Genotype-Phenotype Correlations | Fairway, 2nd Floor, HV Lodge | |||
| Metachromatic Leukodystrophy: Genotype-Phenotype Correlations | Dr. Mike Gelb | |||
| Results of a Delphi Study on Cerebrotendinous Xanthomatosis NBS Guidelines | ||||
| Session Two: Therapeutics in KD, ALD, & MLD, CTX | ||||
| Updates in KD Preclinical Trials | Dr. Steven Gray | |||
| Updates in KD Clinical Trials and Gene Therapy | Dr. Joanne Kurtzberg | |||
| Updates in Treatment of MLD with Lenmeldy | Dr. Paul Orchard | |||
| BREAK | ||||
| Updates in ALD Therapeutics | Dr. Christine Duncan, Dr. Ali Fatemi, Dr. Florian Eichler | |||
| CDCA in Pediatric CTX | Dr. Florian Eichler | |||
| Panel Discussion: Q&A on therapeutics for MLD, ALD, KD and CTX | ||||
| Group Photo | ||||
| 6:00pm | DINNER | Sunrise, 1st Floor HV Lodge | ||
| Wednesday, July 15th | 8AM - 5PM ET | |||
| Time | Location | |||
| 7:00AM | 8:00 AM | BREAKFAST | Fairway, 2nd Floor, HV Lodge | |
| Session Three: Therapeutics in Canavan, Alexander Disease, Pelizaeus-Merzbacher Disease, Aicardi-Goutieres, and Vanishing White Matter Disease | ||||
| Gene Therapy for Canavan Disease | Dr. Amanda Nagy | |||
| Anti-Sense Therapy for Alexander and Pelizaeus-Merzbacher Disease | Dr. Stephanie Keller | |||
| Therapeutics in Aicardi-Goutieres | Dr. Laura Adang | |||
| Therapeutics in Vanishing White Matter Disease | Dr. Florian Eichler | |||
| Panel Discussion: Q&A on therapeutics for Canavan, Alexander, PMD, AGS | ||||
| Family Perspective | Fairway, 2nd Floor, HV Lodge | |||
| BREAK | ||||
| Rapid Approvals and Compassionate Use Programs | ||||
| Session Four: Optimizing Health and Integration of Care | ||||
| Integrating Peds and Adults | Dr. Yedda Li and Dr. Jennifer Orthmann-Murphy | |||
| Transition of Care | Catie Becker | |||
| Incorporating Palliative Care | Dr. Jennifer Rubin | |||
| Panel Discussion | ||||
| Family Perspective | ||||
| 11:50 AM | 12:50 PM | LUNCH | Sunrise, 1st Floor HV Lodge | |
| Optimizing Musculoskeletal Health: Technologies, Medications, and Therapies | Dr. Sally Evans | Fairway, 2nd Floor, HV Lodge | ||
| LCN Workgroups | ||||
| Krabbe NBS Working Session: Data Review and Category Refinement for Infants with Intermediate PSY Levels | Dr. Joanne Kurtzberg & Dr. Margie Ream | |||
| LCN Working Session: Transition of Care for Individuals with Leukodystrophies | Catie Becker & Dr. Yedda Li | |||
| Reports from Groups | ||||
| Closing Remarks | Dr. Robert Stone and Anna Grantham | |||
| 6:00PM | Family Welcome Dinner | All our welcome to attend | Sunrise, 1st Floor HV Lodge | |